N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide

C93H103F10N15O8S4 — CID 160574007

IUPACN-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide
SMILESCc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cc1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)ccc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2ccc(F)cc2F)C2CC2)cn1
InChIInChI=1S/C24H26F3N3O2S.C23H25F3N4O2S.2C23H26F2N4O2S/c1-14-5-9-16(10-6-14)33(31,32)29-22(15-7-8-15)18-13-28-30(24(2,3)4)23(18)17-11-20(26)21(27)12-19(17)25;1-13-5-8-15(11-27-13)33(31,32)29-21(14-6-7-14)17-12-28-30(23(2,3)4)22(17)16-9-19(25)20(26)10-18(16)24;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-11-16(24)8-10-20(18)25;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-10-8-16(24)11-20(18)25/h5-6,9-13,15,22,29H,7-8H2,1-4H3;5,8-12,14,21,29H,6-7H2,1-4H3;2*5,8-13,15,21,28H,6-7H2,1-4H3
InChIKeyRAXIHVCAAJVIQZ-UHFFFAOYSA-N
MW1877.19 g/mol
LogP19.75
Rot. Bonds24

About N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide

N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide (PubChem CID 160574007) has the molecular formula C93H103F10N15O8S4 and a molecular weight of 1877.19 g/mol. Its IUPAC name is N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide.

Molecular Properties

Compound NameN-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide
PubChem CID160574007
Molecular FormulaC93H103F10N15O8S4
Molecular Weight1877.19 g/mol
Exact Mass1875.68
IUPAC NameN-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide
SMILESCc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cc1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)ccc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2ccc(F)cc2F)C2CC2)cn1
InChIInChI=1S/C24H26F3N3O2S.C23H25F3N4O2S.2C23H26F2N4O2S/c1-14-5-9-16(10-6-14)33(31,32)29-22(15-7-8-15)18-13-28-30(24(2,3)4)23(18)17-11-20(26)21(27)12-19(17)25;1-13-5-8-15(11-27-13)33(31,32)29-21(14-6-7-14)17-12-28-30(23(2,3)4)22(17)16-9-19(25)20(26)10-18(16)24;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-11-16(24)8-10-20(18)25;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-10-8-16(24)11-20(18)25/h5-6,9-13,15,22,29H,7-8H2,1-4H3;5,8-12,14,21,29H,6-7H2,1-4H3;2*5,8-13,15,21,28H,6-7H2,1-4H3
InChIKeyRAXIHVCAAJVIQZ-UHFFFAOYSA-N
XLogP19.75
TPSA294.63 Ų
H-Bond Donors4
H-Bond Acceptors19
Rotatable Bonds24
Heavy Atoms130
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001877.19
LogP ≤ 519.75
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}

Analyze N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide?
The IUPAC name of N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide (CID 160574007) is N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide.
What is the SMILES notation for N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide?
The canonical SMILES for N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide is Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cc1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)c(F)cc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2cc(F)ccc2F)C2CC2)cn1.Cc1ccc(S(=O)(=O)NC(c2cnn(C(C)(C)C)c2-c2ccc(F)cc2F)C2CC2)cn1.
What is the InChIKey of N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide?
The InChIKey is RAXIHVCAAJVIQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26F3N3O2S.C23H25F3N4O2S.2C23H26F2N4O2S/c1-14-5-9-16(10-6-14)33(31,32)29-22(15-7-8-15)18-13-28-30(24(2,3)4)23(18)17-11-20(26)21(27)12-19(17)25;1-13-5-8-15(11-27-13)33(31,32)29-21(14-6-7-14)17-12-28-30(23(2,3)4)22(17)16-9-19(25)20(26)10-18(16)24;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-11-16(24)8-10-20(18)25;1-14-5-9-17(12-26-14)32(30,31)28-21(15-6-7-15)19-13-27-29(23(2,3)4)22(19)18-10-8-16(24)11-20(18)25/h5-6,9-13,15,22,29H,7-8H2,1-4H3;5,8-12,14,21,29H,6-7H2,1-4H3;2*5,8-13,15,21,28H,6-7H2,1-4H3.
What are the key properties of N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide?
N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide has a molecular weight of 1877.19 g/mol, XLogP of 19.75, 24 rotatable bonds, 4 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-tert-butyl-5-(2,4-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,5-difluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-4-methylbenzenesulfonamide;N-[[1-tert-butyl-5-(2,4,5-trifluorophenyl)pyrazol-4-yl]-cyclopropylmethyl]-6-methylpyridine-3-sulfonamide is sourced from PubChem (CID 160574007), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).